Edition:
United Kingdom

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

23.50USD
14 Dec 2017
Change (% chg)

$-0.61 (-2.53%)
Prev Close
$24.11
Open
$24.10
Day's High
$24.50
Day's Low
$21.35
Volume
38,503
Avg. Vol
--
52-wk High
$51.90
52-wk Low
$21.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 0.02 -2.772
FY 2017 Jul '17 3.77 -0.166
Apr '17 0.02 -1.554
Jan '17 13.53 4.908
Oct 1.12 -0.301
FY 2016 Jul '16 0.31 -0.546
Apr '16 2.61 0.152
Jan '16 6.86 1.524
Oct 0.12 -6.005
FY 2015 Jul '15 0.87 -0.889
Apr '15 0.12 -1.011
Jan '15 0.56 -1.537
Oct 0.00 -0.434
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.34 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -0.31 0.90 0.88
Price to Sales (TTM) 4.86 3.93 5.40
Price to Book (MRQ) 16.95 4.81 5.38
Price to Tangible Book (MRQ) 17.07 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 1.32 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) 0.00 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -99.30 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 43.34 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,121.18 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 148.03 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 3.13 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 0.00 13.43 15.81
Interest Coverage (TTM) -57.11 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) 39.02 -- --
EBITD - 5 Yr. Avg -411.24 18.46 15.24
Operating Margin (TTM) 38.98 14.50 7.76
Operating Margin - 5 Yr. Avg. -411.30 14.42 10.75
Pre-Tax Margin (TTM) 38.90 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -418.72 14.74 11.17
Net Profit Margin (TTM) 38.90 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -418.72 11.08 7.47
Effective Tax Rate (TTM) 0.00 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,213,828 864,673,321
Net Income/Employee (TTM) -- 112,151,383 101,717,508
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 2.44 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 95.09 11.42 11.00
Return on Assets - 5 Yr. Avg. -1,951.46 13.00 12.43
Return on Investment (TTM) 231.11 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) 2,031.09 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 538.55 -- --
EPS (TTM) % -5.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Opiant Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.94%
# of Holders: 11
Total Shares Held: 60,896
3 Mo. Net Change: 34,046
# New Positions: 10
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 0
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.